eCORE
- Global Health
Team
Group Leader
Susana Otero Romero
Principal Investigator (PI)
Susana Otero Romero, Xavier Martínez Gómez, Lluís Armadans Gil
Researchers
José María Sanchez García, Jose Ángel Rodrigo Pendas, Oleguer Parés Badell, César Llorente Parrado
PhD Students
Blanca Borrás Bermejo, Ricardo Zules Oña
Nursing and Technical Staff
Laia Pinós Tella, Elisa Navarro Royo, Cristian Quintana Alonso, Agustí Gayubas Jurado, Marta Rodríguez Torrecillas, Carmen Ferrer Barbera, Eva del Amo Moran, Ingrid Carbones Fargas, Constanza Olivares Castillo, Mar Fornaguera Padrós, Arnau Peñalver Piñol, Martí Vivet Escale, Gabriela Tejada Panduro, David Guananga Alvarez, Paula Fernandez Torres, Barbara Bolonci, Pía Escobar, Laura Aguirre Cañas
Publications
Otero-Romero S, Lebrun-Frenay C, Reyes S, Amato MP, Campins M, Farez M, Filippi M, Hacohen Y, Hemmer B, Juuti R, Magyari M, Oreja-Guevara C, Siva A, Vukusic S, Tintore M
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Mult Scler. 2023 Jul;29(8):904-925
DOI: 10.1177/13524585231168043
IF: 5.8
Carvajal R, Tur C, Martinez-Gomez X, Bollo L, Esperalba J, Rodriguez M, Pappolla A, Cobo-Calvo A, Carbonell P, Borras-Bemejo B, Rio J, Castillo J, Braga N, Mongay-Ochoa N, Rodrigo-Pendas JA, Vidal-Jordana A, Arrambide G, Rodriguez-Acevedo B, Zabalza A, Midaglia L, Galan I, Comabella M, Sastre-Garriga J, Montalban X, Tintore M, Otero-Romero S
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.
Mult Scler. 2023 Dec;29(14):1841-1848
DOI: 10.1177/13524585231200303
IF: 5.8
Fornaguera M, Pares-Badell O, Carbones-Fargas I, Andres C, Rodrigo-Pendas JA, Borras-Bermejo B, Armadans-Gil L, Tejada G, Guananga D, Vivet-Escale M, Penalver-Pinol A, Torrecilla-Martinez , Del Oso A, Martinez-Gomez X, Anton A, Otero-Romero S
Influenza Vaccine Effectiveness against Hospitalization, Season 2021/22: A Test-Negative Design Study in Barcelona.
Vaccines (Basel). 2023 Sep 2;11(9):1450
DOI: 10.3390/vaccines11091450.
IF: 7.8
Penalver-Pinol A, Benavente Y, Frias-Gomez J, Alguacil J, Santibanez M, Contreras-Llanes M, Peremiquel-Trillas P, Lopez-Querol M, Paytubi S, Pelegrina B, Onieva I, Martinez JM, Fernandez-Gonzalez S, Francisco J, Cano V, Brunet J, Pineda M, Ponce J, Matias-Guiu X, Bosch FX, Sanjose S, Alemany L, Costas L
Occupational exposure to pesticides and endometrial cancer in the Screenwide case-control study.
Environ Health. 2023 Nov 2;22(1):77.
DOI: 10.1186/s12940-023-01028-0
IF: 6
Projects
Caracterización de las infecciones y de su impacto en pacientes con Esclerosis Múltiple en la era de los tratamientos inmunosupresores de alta eficacia (PI23/01654)
Principal Investigator: Susana Otero Romero
Agency: Instituto de Salud Carlos III
Funding: 115,000 €
Period: 2023-2025
Genomics study of COVID-19 vaccine-induced Guillain-Barre syndrome, Autoimmune thrombotic thrombocytopenia/Thrombosis with thrompocytopenia and myocarditis/pericarditis
Principal Investigator: Xavier Martínez Gómez
Agency: Vaccine monitoring Collaboration for Europe (VAC4EU)
Funding: 17,500 USD
Period: 2022-2024
Brand-specific COVID-19 vaccine effectiveness against severe COVID-19 disease in Europe (COVIDRIVE)
Principal Investigator: Susana Otero Romero
Agency: Public-private partnership (membres FISABIO, P95, IABS-EU, THL, AstraZeneca, CureVac, Janssen, Sanofi-Pasteur, GSK, Bavarian Nordic, Moderna, Novavax and Valneva)
Funding: 127,000 €/year
Period: 2021-2023
